Were you looking for information on Erbitux? Erbutux is a common misspelling of Erbitux.
Erbitux® (cetuximab) is licensed for the treatment of two different kinds of cancer. Specifically, it is used to treat:
- Squamous cell carcinoma of the head and neck
- Advanced colorectal cancer (cancer of the colon and rectum) that expresses a protein called epidermal growth factor receptor (EGFR).
This drug is given by injection into a vein once a week. The process will typically take one to two hours, and you will be monitored for an hour afterward to make sure you aren't having an adverse reaction to Erbitux.
(Click Erbitux for more information on this medicine, including how it works, factors that affect your dose, and what to do if you are pregnant or breastfeeding. You can also click any of the links in the box to the right for more information.)